SlideShare una empresa de Scribd logo
1 de 22
  SUPREMO       S elective  U se of  P ostoperative  R adiotherapy aft E r  M astect O my                                        MRC SUPREMO (BIG 2-04)       S elective  U se of  P ostoperative  R adiotherapy aft E r  M astect O my Phase III randomised trial of chest wall RT in intermediate- risk breast cancer Kunkler I, Canney P, Price A,Prescott R, Hophood P,Dixon J, Sainsbury R,Aird E, Thomas G,Bowman A,Thomas J, Bartlett J,Dunlop J, Denvir M,McDonagh T,Russell N  
Background: Trials of postmastectomy RT ,[object Object],[object Object],[object Object],[object Object]
 
Trials of PMRT in premen1-3 N+ + adjuvant CMFchemo (Fowble,1999) Trial No Redn LRR OS % C OS% C+RT P value Int (yr) B.C 183 23% 48 64 0.06 15act Den’k pre 1061 23% 54 62 - 10act Glas pre 141 NS 84 78 .40 5act Dana 83 3% 85 77 >.05 4.4me
Whelan & Levine,JNCI Jan 2005 ,[object Object],[object Object],[object Object]
Effects of RT on breast cancer mortality and all cause mortality after breast conserving / mastectomy and axillary clearance   (EBCTCG; Lancet 2005;366:2087-2106
Oxford overview 2006;  RT trials and breast cancer mortality at 20 yr, mastectomy & axillary clearance by nodal status Breast ca mortality (%) Breast ca mortality(%) 20 yr gain/loss(%) Path nodal status No RT  RT pNO 28.7 30.2 -1.6   NS pN1-3 54.2 47.7 +6.4 2p=0.002 pN =/>4N+ 81.5 70.8 +10.7 2p=0.0008
Interpretation of Overview of RT trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
PMRT 1-3 N+  with 8 or more  nodes DBCG 82b,c trial   Overgaard et al,Radiother Oncol,2007 RT No RT p value LRR 4% 27% <0.001 Overall survival 57% 48% 0.03
Whelan et al JCO 2000 2000;18:1220-29 0.73 - 1.38 1.00 5 YES 0.25 0.70 - 0.89 0.79 13 NO p 95% CI Odds ratio No of studies Anthracycline use
Overall and relapse free survival NEAT trial   (Poole et al,NEJM,2006
Eligibility criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Exclusion criteria ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Randomisation in SUPREMO Chest wall irradiation Vs No chest wall irradiation
Endpoints for SUPREMO : ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Powering of the trial ,[object Object],[object Object],[object Object]
Biological,cardiac, QL and health economic substudies
TRANS-SUPREMO ,[object Object]
Proteins which may affect local relapse ,[object Object],[object Object],[object Object],[object Object],[object Object]
Late cardiac  morbidity   ( EBCTCG,Lancet 2000;355:1757-1770) ,[object Object],[object Object],[object Object],[object Object],field Maximum Heart Distance (MHD) Heart contour Breast contour
SUPREMO collaboration 136 centres in 24 countries
Acknowledgements ,[object Object]

Más contenido relacionado

La actualidad más candente

Radiotherapy In Early Breast Cancer
Radiotherapy In Early Breast CancerRadiotherapy In Early Breast Cancer
Radiotherapy In Early Breast CancerDr.T.Sujit :-)
 
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
San Antonio Breast Cancer Symposium 2007 Highlights – RadiotherapySan Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapyfondas vakalis
 
RADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCERRADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCERfondas vakalis
 
Breast Cancer Radiotherapy
Breast Cancer RadiotherapyBreast Cancer Radiotherapy
Breast Cancer Radiotherapyfondas vakalis
 
Who Benefits From Apbi March2009
Who Benefits From Apbi March2009Who Benefits From Apbi March2009
Who Benefits From Apbi March2009Spectrum Health
 
Early breast cancer treatment radiotherapy
Early breast cancer treatment radiotherapyEarly breast cancer treatment radiotherapy
Early breast cancer treatment radiotherapyYan Vargas
 
New techniques in breast radiotherapy
New techniques in breast radiotherapyNew techniques in breast radiotherapy
New techniques in breast radiotherapyfondas vakalis
 
radiation therapy in ca breast
radiation therapy in ca breast   radiation therapy in ca breast
radiation therapy in ca breast Isha Jaiswal
 
Radiotherapy in Early stage invasive breast carcinoma
Radiotherapy in Early stage invasive breast carcinomaRadiotherapy in Early stage invasive breast carcinoma
Radiotherapy in Early stage invasive breast carcinomaastha17srivastava
 
ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...
ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...
ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...European School of Oncology
 
Radiotherapy practices in GYN malignancies
Radiotherapy practices in GYN malignanciesRadiotherapy practices in GYN malignancies
Radiotherapy practices in GYN malignanciesAjeet Gandhi
 
Radiotherapy lymphoma
Radiotherapy lymphoma Radiotherapy lymphoma
Radiotherapy lymphoma vrinda singla
 
EBRT in breast cancer: Evolution to cutting edge
EBRT in breast cancer: Evolution to cutting edgeEBRT in breast cancer: Evolution to cutting edge
EBRT in breast cancer: Evolution to cutting edgePramod Tike
 
Breast cancer brachytherapy
Breast cancer brachytherapyBreast cancer brachytherapy
Breast cancer brachytherapyRobert Kuske
 
Axillary radiotherapy versus axillary surgery in breast cancer
Axillary radiotherapy versus axillary surgery in breast cancerAxillary radiotherapy versus axillary surgery in breast cancer
Axillary radiotherapy versus axillary surgery in breast cancerAjeet Gandhi
 
Final simulation protocols in GYN malignancies
Final simulation protocols in GYN malignanciesFinal simulation protocols in GYN malignancies
Final simulation protocols in GYN malignanciesAjeet Gandhi
 

La actualidad más candente (20)

Radiotherapy In Early Breast Cancer
Radiotherapy In Early Breast CancerRadiotherapy In Early Breast Cancer
Radiotherapy In Early Breast Cancer
 
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
San Antonio Breast Cancer Symposium 2007 Highlights – RadiotherapySan Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
San Antonio Breast Cancer Symposium 2007 Highlights – Radiotherapy
 
RADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCERRADIOTHERAPY FOR BREAST CANCER
RADIOTHERAPY FOR BREAST CANCER
 
BALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
BALKAN MCO 2011 - E. Vrdoljak - RadiotherapyBALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
BALKAN MCO 2011 - E. Vrdoljak - Radiotherapy
 
Breast Cancer Radiotherapy
Breast Cancer RadiotherapyBreast Cancer Radiotherapy
Breast Cancer Radiotherapy
 
Who Benefits From Apbi March2009
Who Benefits From Apbi March2009Who Benefits From Apbi March2009
Who Benefits From Apbi March2009
 
Radiation Therapy Bc
Radiation Therapy BcRadiation Therapy Bc
Radiation Therapy Bc
 
Early breast cancer treatment radiotherapy
Early breast cancer treatment radiotherapyEarly breast cancer treatment radiotherapy
Early breast cancer treatment radiotherapy
 
New techniques in breast radiotherapy
New techniques in breast radiotherapyNew techniques in breast radiotherapy
New techniques in breast radiotherapy
 
radiation therapy in ca breast
radiation therapy in ca breast   radiation therapy in ca breast
radiation therapy in ca breast
 
Radiotherapy in Early stage invasive breast carcinoma
Radiotherapy in Early stage invasive breast carcinomaRadiotherapy in Early stage invasive breast carcinoma
Radiotherapy in Early stage invasive breast carcinoma
 
ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...
ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...
ABC1 - A. Rodger - Is there still a role for radiotherapy in advanced breast ...
 
7200 35328
7200 353287200 35328
7200 35328
 
Radiotherapy practices in GYN malignancies
Radiotherapy practices in GYN malignanciesRadiotherapy practices in GYN malignancies
Radiotherapy practices in GYN malignancies
 
Radiotherapy lymphoma
Radiotherapy lymphoma Radiotherapy lymphoma
Radiotherapy lymphoma
 
Radiotherapy Breast Cancer
Radiotherapy Breast CancerRadiotherapy Breast Cancer
Radiotherapy Breast Cancer
 
EBRT in breast cancer: Evolution to cutting edge
EBRT in breast cancer: Evolution to cutting edgeEBRT in breast cancer: Evolution to cutting edge
EBRT in breast cancer: Evolution to cutting edge
 
Breast cancer brachytherapy
Breast cancer brachytherapyBreast cancer brachytherapy
Breast cancer brachytherapy
 
Axillary radiotherapy versus axillary surgery in breast cancer
Axillary radiotherapy versus axillary surgery in breast cancerAxillary radiotherapy versus axillary surgery in breast cancer
Axillary radiotherapy versus axillary surgery in breast cancer
 
Final simulation protocols in GYN malignancies
Final simulation protocols in GYN malignanciesFinal simulation protocols in GYN malignancies
Final simulation protocols in GYN malignancies
 

Destacado

συνθήματα στους τοίχους
συνθήματα στους τοίχουςσυνθήματα στους τοίχους
συνθήματα στους τοίχουςfondas vakalis
 
Montgolfieres Airballons
Montgolfieres AirballonsMontgolfieres Airballons
Montgolfieres Airballonsfondas vakalis
 
David Copperfield (Fun)
David Copperfield (Fun)David Copperfield (Fun)
David Copperfield (Fun)fondas vakalis
 
Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...
Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...
Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...fondas vakalis
 
Ioert To The Tumor Bed
Ioert To The Tumor BedIoert To The Tumor Bed
Ioert To The Tumor Bedfondas vakalis
 
Balanced Approach To Esophageal Cancer
Balanced Approach To Esophageal CancerBalanced Approach To Esophageal Cancer
Balanced Approach To Esophageal Cancerfondas vakalis
 
Pictures With Vegetables
Pictures With VegetablesPictures With Vegetables
Pictures With Vegetablesfondas vakalis
 
Endobronchial High Dose Rate Brachytherapy
Endobronchial High Dose Rate BrachytherapyEndobronchial High Dose Rate Brachytherapy
Endobronchial High Dose Rate Brachytherapyfondas vakalis
 
Advancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of CancerAdvancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of Cancerfondas vakalis
 
The Use Of High Energy Protons
The Use Of High Energy ProtonsThe Use Of High Energy Protons
The Use Of High Energy Protonsfondas vakalis
 
Palliative Radiotherapy Using Cone Beam Ct
Palliative Radiotherapy Using Cone Beam CtPalliative Radiotherapy Using Cone Beam Ct
Palliative Radiotherapy Using Cone Beam Ctfondas vakalis
 
Heidelberg Ion Therapy Center
Heidelberg Ion Therapy CenterHeidelberg Ion Therapy Center
Heidelberg Ion Therapy Centerfondas vakalis
 
Cancer Chemo Radiation Concurrent Supplements
Cancer Chemo Radiation Concurrent SupplementsCancer Chemo Radiation Concurrent Supplements
Cancer Chemo Radiation Concurrent Supplementsfondas vakalis
 

Destacado (20)

Winter Places
Winter PlacesWinter Places
Winter Places
 
The Moon
The MoonThe Moon
The Moon
 
Golf
GolfGolf
Golf
 
συνθήματα στους τοίχους
συνθήματα στους τοίχουςσυνθήματα στους τοίχους
συνθήματα στους τοίχους
 
Montgolfieres Airballons
Montgolfieres AirballonsMontgolfieres Airballons
Montgolfieres Airballons
 
David Copperfield (Fun)
David Copperfield (Fun)David Copperfield (Fun)
David Copperfield (Fun)
 
Hellas
HellasHellas
Hellas
 
Driving In Bolivia
Driving In BoliviaDriving In Bolivia
Driving In Bolivia
 
Colorful Life
Colorful LifeColorful Life
Colorful Life
 
Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...
Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...
Methods To Differentiate Radiation Induced Necrosis And Recurrent Disease In ...
 
Ioert To The Tumor Bed
Ioert To The Tumor BedIoert To The Tumor Bed
Ioert To The Tumor Bed
 
Balanced Approach To Esophageal Cancer
Balanced Approach To Esophageal CancerBalanced Approach To Esophageal Cancer
Balanced Approach To Esophageal Cancer
 
Pictures With Vegetables
Pictures With VegetablesPictures With Vegetables
Pictures With Vegetables
 
Endobronchial High Dose Rate Brachytherapy
Endobronchial High Dose Rate BrachytherapyEndobronchial High Dose Rate Brachytherapy
Endobronchial High Dose Rate Brachytherapy
 
Advancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of CancerAdvancing The Prevention And Cure Of Cancer
Advancing The Prevention And Cure Of Cancer
 
The Use Of High Energy Protons
The Use Of High Energy ProtonsThe Use Of High Energy Protons
The Use Of High Energy Protons
 
Pet And Lymphoma
Pet And LymphomaPet And Lymphoma
Pet And Lymphoma
 
Palliative Radiotherapy Using Cone Beam Ct
Palliative Radiotherapy Using Cone Beam CtPalliative Radiotherapy Using Cone Beam Ct
Palliative Radiotherapy Using Cone Beam Ct
 
Heidelberg Ion Therapy Center
Heidelberg Ion Therapy CenterHeidelberg Ion Therapy Center
Heidelberg Ion Therapy Center
 
Cancer Chemo Radiation Concurrent Supplements
Cancer Chemo Radiation Concurrent SupplementsCancer Chemo Radiation Concurrent Supplements
Cancer Chemo Radiation Concurrent Supplements
 

Similar a Selective Use Of Postoperative Radiotherapy AftEr MastectOmy

MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)European School of Oncology
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)European School of Oncology
 
C:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And NeckC:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And NeckGamal Abdul Hamid
 
Advances In Adjuvant Systemic Therapy Of Breast Cancer
Advances In Adjuvant Systemic Therapy Of Breast CancerAdvances In Adjuvant Systemic Therapy Of Breast Cancer
Advances In Adjuvant Systemic Therapy Of Breast Cancerfondas vakalis
 
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLCBALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLCEuropean School of Oncology
 
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLCBALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLCEuropean School of Oncology
 
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerBladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerBJUI
 
Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...
Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...
Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...European School of Oncology
 
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...European School of Oncology
 
SBRT in head and neck cancer
SBRT in  head and neck cancerSBRT in  head and neck cancer
SBRT in head and neck cancerDr Rushi Panchal
 
T4 Larynx cancer can be treated with Chemoradiotherapy
T4 Larynx cancer can be treated with ChemoradiotherapyT4 Larynx cancer can be treated with Chemoradiotherapy
T4 Larynx cancer can be treated with ChemoradiotherapyAjeet Gandhi
 
Small cell lung cancer staging and management
Small cell lung cancer staging and  managementSmall cell lung cancer staging and  management
Small cell lung cancer staging and managementSatyajitPradhanMPMMC
 
Management of Locally advanced NSCLC
Management of Locally advanced NSCLCManagement of Locally advanced NSCLC
Management of Locally advanced NSCLCDr Boaz Vincent
 
Cross trial esophagus updated result
Cross trial esophagus updated resultCross trial esophagus updated result
Cross trial esophagus updated resultBharti Devnani
 
Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...
Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...
Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC European School of Oncology
 
ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...
ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...
ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...European School of Oncology
 

Similar a Selective Use Of Postoperative Radiotherapy AftEr MastectOmy (20)

MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
MON 2011 - Slide 20 - P. Rougier - Gastric and pancreatic cancers (part I)
 
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
MCO 2011 - Slide 22 - P. Rougier - Gastric and pancreatic cancers (part I)
 
C:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And NeckC:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And Neck
 
Advances In Adjuvant Systemic Therapy Of Breast Cancer
Advances In Adjuvant Systemic Therapy Of Breast CancerAdvances In Adjuvant Systemic Therapy Of Breast Cancer
Advances In Adjuvant Systemic Therapy Of Breast Cancer
 
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLCBALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
 
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLCBALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
BALKAN MCO 2011 - T. Cufer - Adjuvant/neo adjuvant systemic therapy in NSCLC
 
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerBladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
 
Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...
Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...
Gene Profiling in Clinical Oncology - Slide 6 - A. Sobrero - Is T4, fewer tha...
 
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
BALKAN MCO 2011 - J. Vermorken - First line treatment of ovarian cancer: surg...
 
SBRT in head and neck cancer
SBRT in  head and neck cancerSBRT in  head and neck cancer
SBRT in head and neck cancer
 
T4 Larynx cancer can be treated with Chemoradiotherapy
T4 Larynx cancer can be treated with ChemoradiotherapyT4 Larynx cancer can be treated with Chemoradiotherapy
T4 Larynx cancer can be treated with Chemoradiotherapy
 
Update Nsclc
Update NsclcUpdate Nsclc
Update Nsclc
 
Small cell lung cancer staging and management
Small cell lung cancer staging and  managementSmall cell lung cancer staging and  management
Small cell lung cancer staging and management
 
Management of Locally advanced NSCLC
Management of Locally advanced NSCLCManagement of Locally advanced NSCLC
Management of Locally advanced NSCLC
 
Cross trial esophagus updated result
Cross trial esophagus updated resultCross trial esophagus updated result
Cross trial esophagus updated result
 
Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...
Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...
Gene Profiling in Clinical Oncology - Slide 11 - J. Albanell Mestres - The Sp...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
BALKAN MCO 2011 - A. Eniu - How to optimize systemic therapy in LABC
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...
ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...
ECCLU 2011 - K. Fizazi - Testicular cancer - Treatment of advanced testicular...
 

Más de fondas vakalis

Esophageal squamous Cancer-therapy-Vakalis
Esophageal squamous Cancer-therapy-VakalisEsophageal squamous Cancer-therapy-Vakalis
Esophageal squamous Cancer-therapy-Vakalisfondas vakalis
 
radiotherapy-pancreatic cancer
radiotherapy-pancreatic cancerradiotherapy-pancreatic cancer
radiotherapy-pancreatic cancerfondas vakalis
 
radiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalisradiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalisfondas vakalis
 
sbrt for inoperable lung cancer
sbrt for inoperable lung cancersbrt for inoperable lung cancer
sbrt for inoperable lung cancerfondas vakalis
 
Spinal cord compression bhf aos study day mar 2014 final
Spinal cord compression bhf  aos study day mar 2014 finalSpinal cord compression bhf  aos study day mar 2014 final
Spinal cord compression bhf aos study day mar 2014 finalfondas vakalis
 
Vakalis breast radiotherapy
Vakalis breast radiotherapyVakalis breast radiotherapy
Vakalis breast radiotherapyfondas vakalis
 
Vakalis - RT for prostate cancer
Vakalis  - RT for prostate cancerVakalis  - RT for prostate cancer
Vakalis - RT for prostate cancerfondas vakalis
 
Her2 positive metastatic breast ca
Her2 positive metastatic breast caHer2 positive metastatic breast ca
Her2 positive metastatic breast cafondas vakalis
 
Advanced breast cancer
Advanced breast cancerAdvanced breast cancer
Advanced breast cancerfondas vakalis
 
Second line therapy for nsclc
Second line therapy for nsclcSecond line therapy for nsclc
Second line therapy for nsclcfondas vakalis
 
HER2 negative metastatic breast ca
HER2 negative metastatic breast caHER2 negative metastatic breast ca
HER2 negative metastatic breast cafondas vakalis
 
Radiobiology behind dose fractionation
Radiobiology behind dose fractionationRadiobiology behind dose fractionation
Radiobiology behind dose fractionationfondas vakalis
 
2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionation2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionationfondas vakalis
 
RECTAL CA - VAKALIS . X
RECTAL CA - VAKALIS . XRECTAL CA - VAKALIS . X
RECTAL CA - VAKALIS . Xfondas vakalis
 
Vakalis - gastric ca radiotherapy
Vakalis - gastric ca radiotherapyVakalis - gastric ca radiotherapy
Vakalis - gastric ca radiotherapyfondas vakalis
 

Más de fondas vakalis (20)

Esophageal squamous Cancer-therapy-Vakalis
Esophageal squamous Cancer-therapy-VakalisEsophageal squamous Cancer-therapy-Vakalis
Esophageal squamous Cancer-therapy-Vakalis
 
radiotherapy-pancreatic cancer
radiotherapy-pancreatic cancerradiotherapy-pancreatic cancer
radiotherapy-pancreatic cancer
 
radiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalisradiotherapy of bone metastases,Vakalis
radiotherapy of bone metastases,Vakalis
 
sbrt for inoperable lung cancer
sbrt for inoperable lung cancersbrt for inoperable lung cancer
sbrt for inoperable lung cancer
 
Spinal cord compression bhf aos study day mar 2014 final
Spinal cord compression bhf  aos study day mar 2014 finalSpinal cord compression bhf  aos study day mar 2014 final
Spinal cord compression bhf aos study day mar 2014 final
 
Vakalis breast radiotherapy
Vakalis breast radiotherapyVakalis breast radiotherapy
Vakalis breast radiotherapy
 
Vakalis - RT for prostate cancer
Vakalis  - RT for prostate cancerVakalis  - RT for prostate cancer
Vakalis - RT for prostate cancer
 
Her2 positive metastatic breast ca
Her2 positive metastatic breast caHer2 positive metastatic breast ca
Her2 positive metastatic breast ca
 
nonsquamous NSCLC
nonsquamous NSCLCnonsquamous NSCLC
nonsquamous NSCLC
 
Advanced breast cancer
Advanced breast cancerAdvanced breast cancer
Advanced breast cancer
 
Second line therapy for nsclc
Second line therapy for nsclcSecond line therapy for nsclc
Second line therapy for nsclc
 
Vegf in colorectal ca
Vegf in colorectal caVegf in colorectal ca
Vegf in colorectal ca
 
HER2 negative metastatic breast ca
HER2 negative metastatic breast caHER2 negative metastatic breast ca
HER2 negative metastatic breast ca
 
817731 slides
817731 slides817731 slides
817731 slides
 
Radiobiology behind dose fractionation
Radiobiology behind dose fractionationRadiobiology behind dose fractionation
Radiobiology behind dose fractionation
 
2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionation2012-michael joiner-hypofractionation
2012-michael joiner-hypofractionation
 
RECTAL CA - VAKALIS . X
RECTAL CA - VAKALIS . XRECTAL CA - VAKALIS . X
RECTAL CA - VAKALIS . X
 
Vakalis - gastric ca radiotherapy
Vakalis - gastric ca radiotherapyVakalis - gastric ca radiotherapy
Vakalis - gastric ca radiotherapy
 
Vakalis.X H&N CANCER
Vakalis.X  H&N CANCERVakalis.X  H&N CANCER
Vakalis.X H&N CANCER
 
Vakalis pancreas
Vakalis pancreasVakalis pancreas
Vakalis pancreas
 

Último

call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 

Último (20)

call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 

Selective Use Of Postoperative Radiotherapy AftEr MastectOmy

  • 1.   SUPREMO     S elective U se of P ostoperative R adiotherapy aft E r M astect O my                                     MRC SUPREMO (BIG 2-04)     S elective U se of P ostoperative R adiotherapy aft E r M astect O my Phase III randomised trial of chest wall RT in intermediate- risk breast cancer Kunkler I, Canney P, Price A,Prescott R, Hophood P,Dixon J, Sainsbury R,Aird E, Thomas G,Bowman A,Thomas J, Bartlett J,Dunlop J, Denvir M,McDonagh T,Russell N  
  • 2.
  • 3.  
  • 4. Trials of PMRT in premen1-3 N+ + adjuvant CMFchemo (Fowble,1999) Trial No Redn LRR OS % C OS% C+RT P value Int (yr) B.C 183 23% 48 64 0.06 15act Den’k pre 1061 23% 54 62 - 10act Glas pre 141 NS 84 78 .40 5act Dana 83 3% 85 77 >.05 4.4me
  • 5.
  • 6. Effects of RT on breast cancer mortality and all cause mortality after breast conserving / mastectomy and axillary clearance (EBCTCG; Lancet 2005;366:2087-2106
  • 7. Oxford overview 2006; RT trials and breast cancer mortality at 20 yr, mastectomy & axillary clearance by nodal status Breast ca mortality (%) Breast ca mortality(%) 20 yr gain/loss(%) Path nodal status No RT RT pNO 28.7 30.2 -1.6 NS pN1-3 54.2 47.7 +6.4 2p=0.002 pN =/>4N+ 81.5 70.8 +10.7 2p=0.0008
  • 8.
  • 9. PMRT 1-3 N+ with 8 or more nodes DBCG 82b,c trial Overgaard et al,Radiother Oncol,2007 RT No RT p value LRR 4% 27% <0.001 Overall survival 57% 48% 0.03
  • 10. Whelan et al JCO 2000 2000;18:1220-29 0.73 - 1.38 1.00 5 YES 0.25 0.70 - 0.89 0.79 13 NO p 95% CI Odds ratio No of studies Anthracycline use
  • 11. Overall and relapse free survival NEAT trial (Poole et al,NEJM,2006
  • 12.
  • 13.
  • 14. Randomisation in SUPREMO Chest wall irradiation Vs No chest wall irradiation
  • 15.
  • 16.
  • 17. Biological,cardiac, QL and health economic substudies
  • 18.
  • 19.
  • 20.
  • 21. SUPREMO collaboration 136 centres in 24 countries
  • 22.